دورية أكاديمية
Phase i clinical trialto evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM® at different dose strengths in subjects with Schizophrenia or Schizoaffective disorder (PRISMA-1)
| العنوان: | Phase i clinical trialto evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM® at different dose strengths in subjects with Schizophrenia or Schizoaffective disorder (PRISMA-1) |
|---|---|
| المؤلفون: | Llaudó, J., Ayani, I., Monreal, M., Martínez-González, J., Gutierro, I. |
| المصدر: | In Clinical Therapeutics August 2015 37(8) Supplement:e47-e47 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 01492918 |
|---|---|
| DOI: | 10.1016/j.clinthera.2015.05.141 |